Related Experiment Videos
Safety of parenteral hydroxypropyl beta-cyclodextrin
T O Carpenter1, A Gerloczy, J Pitha
1Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
Journal of Pharmaceutical Sciences
|February 1, 1995
Summary
Hydroxypropyl beta-cyclodextrin showed no adverse effects in a patient but caused agitation and edema in animals. These effects may stem from complex formation with lipid mediators like prostaglandins.
Area of Science:
- Pharmacology
- Biochemistry
- Toxicology
Background:
- Hydroxypropyl beta-cyclodextrin is used intravenously.
- A patient received 1.5 g/kg in 1985 without adverse effects.
Observation:
- Rabbits and dogs experienced rare agitation and pulmonary edema, respectively.
- The study analyzed complications based on symptoms and effects on cholesterol biochemistry in rats.
Findings:
- Parenteral hydroxypropyl beta-cyclodextrin may cause adverse effects through complex formation with lipid mediators.
- Prostaglandins are identified as a potential example of these lipid mediators.
Implications:
- Complex formation can increase the influence of lipid mediators, potentially amplifying organismal responses.
- Understanding these interactions is crucial for assessing the safety of hydroxypropyl beta-cyclodextrin administration.